Skip to content

The effect of pulmonary rehabilitation in COPD: Dynamic hyperinflation and systemic inflammation during daily activities.

The effect of pulmonary rehabilitation on respiratory impairments, dyspnea and systemic inflammation during daily activities (ADL) in patients with COPD.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27345
Enrollment
26
Registered
2012-08-20
Start date
2012-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

The multidisciplinary outpatient pulmonary rehabilitation program consists of a 10-week training program with 2 hour sessions, 3 times a week. The pulmonary rehabilitation program also includes educat

Sponsors

Radboud University Nijmegen Medical Centre, Department of Pulmonary diseases
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Stable COPD GOLD I-III; 2. Dynamic hyperinflation during ADL.

Exclusion criteria

Exclusion criteria: 1. Long term oxygen therapy at home; 2. Severe ADL-limiting cardiac or neuromuscular disease; 3. Co-existing lung disease other than COPD; 4. Other inflammatory diseases; 5. Treatment with systemic anti-inflammatory drugs; 6. Previous participation in rehabilitation program (<2 year). Extra exclusion criterium for control COPD patients: 1. Participation in supervised physical therapy program.

Design outcomes

Primary

MeasureTime frame
1. Dynamic hyperinflation; 2. Dyspnea; 3. Biomarkers of systemic inflammation after ADL. Dynamic hyperinflation and other respiratory impairments during ADL will be measured using the Oxycon Mobile (Viasys Healthcare, Germany), which is a portable breath-by-breath system, consisting of a face mask with turbine volume transducer and integrated O2 and CO2 gas analyzers. Subjects will be asked to rate their shortness of breath using a 10-point Borg scale at start and end of each ADL. Systemic inflammation will be characterized by measuring the number of circulating leukocytes (standard laboratory tests), and plasma levels of interleukins.

Contacts

Public ContactL.M. Willems

UCCZ Dekkerswald, 4611

L.Willems@LONG.umcn.nl+31 (0)24 6859580

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)